These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11972093)

  • 1. Modeling administrative outcomes in fever and neutropenia: clinical variables significantly influence length of stay and hospital charges.
    Rosenman M; Madsen K; Hui S; Breitfeld PP
    J Pediatr Hematol Oncol; 2002 May; 24(4):263-8. PubMed ID: 11972093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of electronic data for model validation and refinement: bacteremia risk in children with fever and neutropenia.
    Madsen K; Rosenman M; Hui S; Breitfeld PP
    J Pediatr Hematol Oncol; 2002 May; 24(4):256-62. PubMed ID: 11972092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital resource utilization in childhood cancer.
    Rosenman MB; Vik T; Hui SL; Breitfeld PP
    J Pediatr Hematol Oncol; 2005 Jun; 27(6):295-300. PubMed ID: 15956880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia.
    Bash RO; Katz JA; Cash JV; Buchanan GR
    Cancer; 1994 Jul; 74(1):189-96. PubMed ID: 8004575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis.
    Odetola FO; Gebremariam A; Freed GL
    Pediatrics; 2007 Mar; 119(3):487-94. PubMed ID: 17332201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of interhospital transfers on outcomes in an academic medical center. Implications for profiling hospital quality.
    Gordon HS; Rosenthal GE
    Med Care; 1996 Apr; 34(4):295-309. PubMed ID: 8606555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charges and complications associated with the medical evaluation of febrile young infants.
    Condra CS; Parbhu B; Lorenz D; Herr SM
    Pediatr Emerg Care; 2010 Mar; 26(3):186-91. PubMed ID: 20179660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charges for childhood asthma by hospital characteristics.
    Meurer JR; Kuhn EM; George V; Yauck JS; Layde PM
    Pediatrics; 1998 Dec; 102(6):E70. PubMed ID: 9832598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia.
    Baorto EP; Aquino VM; Mullen CA; Buchanan GR; DeBaun MR
    Cancer; 2001 Aug; 92(4):909-13. PubMed ID: 11550165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lengths of stay and costs associated with children's hospitals.
    Merenstein D; Egleston B; Diener-West M
    Pediatrics; 2005 Apr; 115(4):839-44. PubMed ID: 15805353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children.
    Raisch DW; Holdsworth MT; Winter SS; Hutter JJ; Graham ML
    Value Health; 2003; 6(2):158-66. PubMed ID: 12641866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postadmission function best predicts acute hospital outcomes after stroke.
    Bohannon RW; Lee N; Maljanian R
    Am J Phys Med Rehabil; 2002 Oct; 81(10):726-30. PubMed ID: 12362111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential for bias in severity adjusted hospital outcomes data: analysis of patients with rheumatic disease.
    Rosenthal GE
    J Rheumatol; 1994 Apr; 21(4):721-7. PubMed ID: 8035400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiology and risk factors for prolonged hospital length of stay in children with leukemia and bacteremia. Cohort study].
    Taicz M; Pérez MG; Reijtman V; Mastroianni A; Escarra F; García ME; Varela AN; Guitter M; Romero J; Ghibaudi G; Gómez S; Bologna R
    Rev Chilena Infectol; 2018; 35(3):233-238. PubMed ID: 30534901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charges and lengths of stay attributable to adverse patient-care events using pediatric-specific quality indicators: a multicenter study of freestanding children's hospitals.
    Kronman MP; Hall M; Slonim AD; Shah SS
    Pediatrics; 2008 Jun; 121(6):e1653-9. PubMed ID: 18519468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk prediction in pediatric cancer patients with fever and neutropenia.
    Hakim H; Flynn PM; Srivastava DK; Knapp KM; Li C; Okuma J; Gaur AH
    Pediatr Infect Dis J; 2010 Jan; 29(1):53-9. PubMed ID: 19996816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case-Control Study on the Impact of Ventilator-Associated Tracheobronchitis in the PICU.
    Wheeler DS; Whitt JD; Lake M; Butcher J; Schulte M; Stalets E
    Pediatr Crit Care Med; 2015 Jul; 16(6):565-71. PubMed ID: 25850864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting survival, length of stay, and cost in the surgical intensive care unit: APACHE II versus ICISS.
    Osler TM; Rogers FB; Glance LG; Cohen M; Rutledge R; Shackford SR
    J Trauma; 1998 Aug; 45(2):234-7; discussion 237-8. PubMed ID: 9715178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic impact of neutropenia and febrile neutropenia in breast cancer: estimates from two national databases.
    Gandhi SK; Arguelles L; Boyer JG
    Pharmacotherapy; 2001 Jun; 21(6):684-90. PubMed ID: 11401182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ICD-9-based illness severity score: a new model that outperforms both DRG and APR-DRG as predictors of survival and resource utilization.
    Rutledge R; Osler T
    J Trauma; 1998 Oct; 45(4):791-9. PubMed ID: 9783623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.